Iambic Therapeutics logo

Iambic Therapeutics

Clinical-stage life-science and technology company that develops medicines using an AI-driven discovery and development platform.
San Diego, United States

Current Funding Stage

Series B

Current recognized equity stage. The rounds below remain the historical funding record.

Funding Rounds

Funding Round: Oversubscribed financing
Funding Date: 10 Nov, 2025

Funding Round: Series B
Funding Date: 3 Oct, 2023
Raised Amount: $100M

Funding Round: Series A
Funding Date: 14 Jul, 2021
Raised Amount: $53M

Funding Round: Seed
Funding Date: Unknown
Raised Amount: $3M

Investors